What is Meril?
Founded in 2006, Meril operates as a comprehensive MedTech platform dedicated to the innovation, design, and development of advanced medical devices. The company boasts a diverse product portfolio spanning critical therapy areas, including cardiovascular solutions (with a focus on structural heart devices), orthopedics (encompassing implants and surgical robots), in-vitro diagnostics, and endo-surgery. Meril's commitment to robust research and development, coupled with world-class manufacturing capabilities and extensive distribution networks, has solidified its leading market position within India and established a significant business presence in over 100 countries. Its strategic investments in education and training programs further enhance its market influence and technological leadership.
How much funding has Meril raised?
Meril has raised a total of $410M across 2 funding rounds:
Private Equity
$210M
Private Equity
$200M
Private Equity (2022): $210M with participation from Warburg Pincus
Private Equity (2025): $200M led by ADIA
Key Investors in Meril
ADIA
ADIA, established in 1976, manages a globally diversified investment portfolio across various asset classes. Headquartered in Abu Dhabi, United Arab Emirates, the firm is known for its significant capital deployment in established and growing enterprises.
Warburg Pincus
Warburg Pincus is a leading global private equity firm specializing in growth investing. The firm partners with management teams to build long-term value across diverse industries and geographies, leveraging extensive experience and strategic insight.
What's next for Meril?
With the infusion of $200M in its latest strategic investment and a cumulative funding of $410M, Meril is well-positioned for its next phase of enterprise-level growth. The company is expected to leverage this capital to accelerate its research and development initiatives, expand its product offerings in high-demand therapy areas, and deepen its global market penetration. Meril's focus on innovation in cardiovascular, orthopedic, and surgical technologies, combined with its established infrastructure, suggests a strategic direction towards consolidating its leadership and potentially exploring new technological frontiers in the MedTech landscape. This significant backing will likely fuel further advancements and reinforce its competitive edge.
See full Meril company page
